Pune, November 6, 2025: Specialty chemical compounds producer Clean Science and Technology Ltd (NSE: CLEAN, BSE: 543318) reported consolidated income of ₹245 crore for the quarter ended September 30, 2025 (Q2FY26), up 3% year-on-year (YoY), although sequentially flat. The firm’s revenue after tax (PAT) got here in at ₹55 crore, down 6% YoY and 21% QoQ, impacted by greater uncooked materials bills and reasonable quantity progress.
Clean Science and Technology Ltd is among the many world’s largest producers of efficiency and specialty chemical compounds. This consists of MEHQ, BHA, Guaiacol, and HALS collection. It caters to purchasers throughout prescription drugs, agrochemicals, polymers, and FMCG sectors. Its exports contribute over 60% of the income. The firm was based in 2003 and is listed on NSE and BSE. It trades beneath the tickers respectively CLEAN and 543318 is a part of the Nifty Smallcap 250 index.
Key Financial Highlights (₹ crore)
The firm generated ₹245 crore in income from operations through the quarter. This marked a 3% YoY improve from ₹238 crore. This additionally marks a 1% QoQ improve from ₹243 crore. The EBITDA, nevertheless, fell to ₹87 crore, a 3% YoY decline and a 13% QoQ decline. Even the EBITDA margin decreased to 36.4% from 38.2% in Q2FY25. The losses prolonged to PBT and PAT as each additionally fell. PBT reached ₹75 crore, a ten% YoY decline. And the PAT reached ₹55 crore, a 6% YoY decline.
The quarter finish additionally marked the tip of the primary half of the monetary 12 months. During H1FY26, the corporate’s consolidated income reached ₹488 crore, a 6% YoY improve. whereas PAT was ₹125 crore, sustaining final 12 months’s stage. EBITDA margin for the half-year stood at 38.9% versus 40.4% in H1FY25.
Business & Segmental Highlights
The numerous segments had comparable monetary outcomes individually. The efficiency chemical compounds section contributed 75% of whole income in H1FY26. This was led by robust demand within the HALS (Hindered Amine Light Stabilizers) collection. Whereas the Pharma and Agro Intermediates section fashioned 16%. It was adopted by FMCG chemical compounds, which have been 9% of whole income. The export share remained strong at 63%. It spanned 35+ nations throughout Europe, the Americas, China, and India. The firm continues to function with zero debt. It has a wholesome consolidated money place of ₹9 crore as of September 30, 2025.
Management & Governance
The firm is led by technocrat promoters Ashok Boob (MD) and Siddharth Sikchi (ED). The give attention to R&D-driven progress. It operates 4 unbiased R&D labs with 90 scientists and 15+ core chemistries. The Board consists of trade veterans similar to Pradeep Rathi, Prof. G. D. Yadav, and Madhu Dubhashi. This underscores robust governance requirements.
Sustainability & ESG Focus
Clean Science integrates ESG ideas by measurable targets. It has 65% renewable vitality share. It additionally plans to put in 20 MW of photo voltaic capability. The firm goals to chop GHG emissions, water use, and vitality consumption by 15% over 5 years. It has to date invested ₹18 crore in CSR over the previous three years. Its CSR actions give attention to healthcare, schooling, and sustainability initiatives.
Market Snapshot
The shares of Clean Science and Technology Limited closed at ₹983.80 on November 06, 2025. This is a 0.01% or ₹0.10 lower from its earlier shut of ₹983.90. The intraday vary was between ₹960.00 and ₹992.20. The firm has had an honest buying and selling session. Its whole market capitalisation stood at ₹10,455.22 crore. Further, it had whole traded worth and quantity of ₹67.58 crore and 6.92 lakh shares, respectively.
REF: https://nsearchives.nseindia.com/company/CLEAN_06112025134404_Investor_Presentation_06112025.pdf
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting information and market-related content material. However, inadvertent errors or omissions could often happen.
If you’ve any issues, questions, or want to level out any discrepancies in our content material, please be at liberty to put in writing to us at content [email protected].
Please be aware that the knowledge shared is meant solely for informational functions and doesn’t make any funding suggestions